BD² has committed $105+ million to research on bipolar disorder in recent years. It’s funded by the Sergey Brin Family Foundation and three other philanthropic investors. For anyone interested in funding bipolar research, this would be my recommendation.
Mental health is one of Wellcome’s three strategic priorities. They’ve funded a lot of impactful research on SMIs, including AVATAR therapy for psychosis (as highlighted by Kestrel) and the first new drug for schizophrenia in 30 years.
BD² has committed $105+ million to research on bipolar disorder in recent years. It’s funded by the Sergey Brin Family Foundation and three other philanthropic investors. For anyone interested in funding bipolar research, this would be my recommendation.
Mental health is one of Wellcome’s three strategic priorities. They’ve funded a lot of impactful research on SMIs, including AVATAR therapy for psychosis (as highlighted by Kestrel) and the first new drug for schizophrenia in 30 years.